Skip to content

Novartis Fellowships

Novartis Institutes for Biomedical Research – Fellowships in Early Clinical Development

The Novartis Institutes for BioMedical Research (NIBR) in conjunction with MCPHS University offers 5 unique post-PharmD Fellowships in early clinical drug development:

  • Clinical Operations – General Medicine
  • Biomarker Development (BMD)
  • Clinical Operations – Translational Clinical Oncology (TCO)
  • Clinical Quality Assurance (QA)
  • Regulatory Affairs (RA)

These Fellowships are two-year post-PharmD Fellowship programs designed to provide highly motivated candidates the unique opportunity to gain practical experience in early clinical drug development at NIBR. These programs also present the opportunity to increase academic skills in collaboration with MCPHS University. Collectively, the NIBR Fellowships are designed to provide a comprehensive, high-quality postdoctoral experience.

NIBR Overview

NIBR is the global pharmaceutical research organization for Novartis committed to discovering innovative medicines to treat diseases with high unmet medical need. With more than 6,000 scientists and physicians around the world, our open and entrepreneurial culture encourages collaboration as we work to push the boundaries of science to change the practice of medicine.

The culture of our organization is firmly grounded in its values outlining what is expected of each associate. Our six core values serve as the foundation to guide our actions: Innovation, Quality, Collaboration, Performance, Courage, and Integrity. A large part of our culture is helping associates develop. Please see the NIBR Website for additional information.

Fellowship Objectives

The Fellowship is comprised of the NIBR component and MCPHS University component. Fellows will spend the majority of their time at NIBR obtaining real world clinical trial experience with a smaller portion of time dedicated to MCPHS University activities. Over the course of the Fellowship, the Fellows will:

  • Learn the phases of drug development, regulatory process requirements, and clinical regulations such as current good clinical practice (cGCP) requirements and International Conference on Harmonization (ICH) guidelines
  • Gain practical experience in the drug development process as an integral part of a development team working on actual early phase development clinical studies in various phases from start-up through close-out
  • Utilize clinical and scientific knowledge to understand the design and conduct of early phase clinical studies
  • Participate in didactic seminars, workshops, and group forums related to clinical research
  • Expand technical writing proficiency of clinical documents such as study protocols and reports
  • Strengthen presentation skills at internal meetings and at national conferences

Please see our brochure for additional details.